SlideShare a Scribd company logo
B Y
M S . J I G I S H A P A N C H O L I
H E A D
D E P T . O F B I O C H E M I S T R Y & M I C R O B I O L O G Y
I N D I A N I N S T I T U T E O F A Y U R V E D I C
P H A R M A C E U T I C A L S C I E N C E S
G U J A R A T A Y U R V E D U N I V E R S I T Y
J A M N A G A R
Mechanism of Bacterial
Pathogenesis
Introduction
Introduction
 Humans and animals have abundant bacterial flora that are
usually harmless.
 A general balance exists between host and his environment.
 The host- parasite interaction is influenced by host factors as
well as the infecting microbe.
 The outcome of this interaction can range from no
demonstrable effect to death.
 Majority of the free living organisms are saprophytes.
Definitions
Commensal
 Commensals live in complete harmony with the
animal body (host) without causing any harm to it.
 The commensals constitute the normal bacterial
flora of the body, such as S. epidermidis of skin and
E. coli of gastrointestinal tract.
 They subsist on secretions, food residues or waste
products of the body.
 They serve important functions in their hosts, like
production of vitamins, protection of host from
colonisation with pathogenic organism etc.
Opportunistic Pathogen
 These are the commensals or saprophytes which can
produce disease when the body resistance is lowered.
 Example:
 Candida albicans – a causal agent of opportunistic
oral and genital infections in humans
 Staphylococcus aureus- occurs as commensal on
human skin but may cause Staph infections
Pathogen
 A micro organism capable of producing disease is
called as pathogen.
 Pathogenicity is the ability of a class of bacteria
(Pathogen) to produce disease.
 Examples:
 Bacillus anthracis causes anthrax
 Clostridium tetani causes tetanus
 Salmonella typhi causes typhoid
Virulence
 Virulence is the measure of the degree of
pathogenicity and depends on invasiveness and
toxigenecity of the organism.
 The ability of a bacteria to cause disease is described
in terms of the number of infecting bacteria, the
route of entry into the body, the effects of host
defense mechanisms and intrinsic characteristics of
the bacteria called as virulence factors.
Infection
 Infection may be defined as lodgement and
multiplication of an infectious agent in the body.
 All infections do not invariably result in disease.
 Some infections may remain asymptomatic and
others may lead to development of signs and
symptoms (disease) after break down of host-
parasite relationship in favour of the parasite.
Portal of Entry
 The infectious agent enters the body by one of the
following routes:
 Oral
 Respiratory
 Genitourinary
 Conjunctiva
 Cutaneous
Incubation Period
 The time interval between the entry of the infectious
agent and the onset of clinical manifestations of
disease is called incubation period.
 The infective agent, after reaching the selective
tissue, undergoes multiplication during this period.
 The period may be as short as minutes to as long as
thirty years in the case of variant Creutzfeldt- Jakob
disease
Clinical Manifestation
 An infection that does not cause any detectable
manifestation is known as in apparent or subclinical
infection.
 A person with symptomless infection is called as carrier.
 In some diseases, either because of inadequate treatment
or immune response, the infectious agent us not
eliminated, leading to carrier state.
 Carriers may be temporary or chronic.
 Temporary carrier state lasts for less than six months,
whereas the chronic carrier is the one who excretes
the disease producing organisms for indefinite period of
several years or throughout life.
 Examples: Cholera, polio, diphtheria, meningitis, typhoid
etc.
 Following infection, some pathogens may remain in
latent or dormant form in host tissues and proliferate
when host resistance is lowered producing clinical
disease. This is called as Latent infection. Example:
HIV
 Primary infection is referred to the first or initial
infection caused by an infecting organism.
 Subsequent infections by the same parasite in the host is
called as re infection.
 When the body resistance of a patient is lowered by a pre
existing infectious disease or during some treatment, a
new micro organism sets up an infection which is called
as secondary infection. Example: A vaginal yeast
infection after taking antibiotics to remove bacterial
infection.
 When a new infection from patient or healthy staff
carrier is set up in an already diseased person, it is called
as cross infection.
 Cross infections acquired in hospitals are called as
hospital acquired or nosocomial infections.
 Infection where the typical or characteristic
manifestations of a particular disease is lacking, it is
called as atypical infection. Eg: Atypical mycobacterial
infections in HIV patients
 An iatrogenic infection is defined as physician
induced infection resulting from drug therapy or
diagnostic procedure, eg. Hepatitis B following blood
transfusion.
Evolution of Infection
 From the portal entry the parasites may directly invade the
tissue or may pass through lymphatic channels into blood
stream for dissemination into internal organs.
 In majority of the instances, the parasites get destroyed by
the host defense mechanisms.
 When the host resistance fails, an acute inflammatory
response is developed which is characterized by vascular
dilatation, marked exudation of plasma and accumulation
of leucocytes with the formation of pus.
 The pus forming bacteria are termed pyogenic, eg. S.
aureus, S. pyogenes.
CAPSULE
ADHESINS
INVASIVENESS
EXOENZYMES
TOXINS
Bacterial Virulence factors
Capsule
 Capsule is one of the most
important virulence
factors.
 They surround many
bacterial cells which shield
the bacteria from immune
and phagocytic response.
 They are made up of either
carbohydrates or proteins
 Capsule inhibits
phagocytosis by means of
several ways:
 1. Capsule prevents
interaction between
antibody and C3 bound to
outer membrane of
bacteria and their
respective receptors on
phagocytic cells.
 Complement activation is
inhibited by the capsule.

Adhesins
 The pathogenesis of many bacteria depend on the
ability to adhere to mucosal cells as a first step.
 With adhesion factors, many bacteria adhere to
epithelial or endothelial cell linings of bladder,
intestine and blood vessels.
 Types: Pili
Lipopolysaccharide
M proteins
 Pili: in most cases pili serve
as adhesion factor. Many of
the adhesin proteins are
present at the tip of pili and
binds tightly to the target
tissue.
 Examples of bacteria
producing pili as adhesion
factor:
 E.coli
 Neisseria gonorrhoeae
 Lipopolysaccharides: They
are present in the outer
membrane of gram –ve
bacteria.
 M protein: the
expression of M proteins
on the cell membrane of
bacteria mediates their
adherence to epithelial
cells as seen in S.
pyogenes that causes
pharyngitis, which
appears to be directly
related to the production
of M proteins.
Invasiveness
 Invasiveness of bacteria appears to be multifactorial and
complex process. Invasive bacteria either destroy the
barrier or penetrate into the cells of the barrier.
 Examples:
 1. Shigella: a series of invasive proteins are involved:
a. Proteins called as “invasion plasmid antigens
(IPA)” expressed on outer membrane permit the
bacterium to bind to the luminal surface of mucosal M
cells of intestine then endocytosis occurs which is
followed by rapid exit of the bacterium from the
endosome into the cytoplasm.
b. Another protein, known as
“intracellular spread protein
(ICS)” expressed on the outer
membrane of the bacterium,
allows to interact with the
host cell integrins.
Following interaction, the
bacterium travels towards the
cell membrane which forms a
protrusion and fuses with cell
membranes of adjacent cells,
thereby enabling Shigella to
diffuse from cell to cell.
 2. Enteropathogenic Yersinia: they secrete an
invasion protein which promotes binding of bacteria
to the host cells, which in turn stimulates the cell to
invaginate and take in the bacteria.
 3. Neisseria gonorrhoea: with its pili adhere to
mucosal cells. The bacteria also contains an enzyme
that dissolves mucosal cell lining and thereby
enables the organism to penetrate submucosal
tissues.
Exoenzymes
 Many bacteria release enzymes that can damage host tissue in
a variety of mechanisms:
 1. Enzymes that break down collagen (eg.: collagenase,
hyaluronidase) and fibrin (eg: fibrinolysins) allows better
penetration of microbes into tissues.
 2. Enzymes that break down cellular material (Eg: proteases,
lecithinases) are associated with many Clostridia
 3. Enzymes that modify and inactivate antibiotics (eg. Beta
lactamase) hydrolyses the beta lactum ring of the antibiotics.
The beta lactamase for penicillin and cephalosporin are called
penicillinase and cephalosporinase respectively.
Mechanism of bacterial pathogenesis
Toxins
 Bacterial toxins directly harm tissue or trigger
destructive biological activities.
 They are classified into two categories: Exotoxins
and Endotoxins
Exotoxins
 They are proteins produced and released extra
cellularly from the bacterial cell to cause toxicity.
 They are produced by both Gram +ve and Gram –ve
bacteria.
 In many cases the toxin is encoded by the plasmid,
eg: LT and ST toxins of E.coli, tetanus toxin of Cl.
tetani or a lysogenic phage, eg: C. diphtheriae, Cl.
botulinum
Mechanism of bacterial pathogenesis
 Most exotoxins have two
structural domains, “A”
subunit (active
domain)that causes cell
cytotoxicity and “B”
domain (binding domain)
subunit that binds the A
domain to specific cellular
receptors.
 “A “subunit is transferred
to the interior of the cell,
where the cell injury is
induced
Functional types of Exotoxins
 Enterotoxins: Affect gastrointestinal tract and
include cholera toxin, E.coli toxin
 Neurotoxins: Affect nervous system and include
botulinum toxin, tetanus toxin
 Cytotoxin: Affect cells in a variety of tissues and
include diphtheria toxin, pseudomonas toxin A
Identification of exotoxins
 Ileal loop test: Ligated loops
of ileum are inoculated with
enterotoxin producing bacteria
(V. cholerae, Enterotoxigenic
E.coli), accumulation of fluid
occur in the lumen in the
organism is toxigenic.
 Cell culture test: to
monolayers of sensitive cells
(eg: Vero cells) bacteria free
culture filtrate is added and
incubated. The monolayer will
be disrupted if the filtrate
contains toxin (eg Vero
cytotoxin of E.coli)
 Serological test (Immunoassay): Since the enterotoxin
are immunogenic, antisera can be used to detect the
presence of toxin in specimens (eg: faecal material) or in
culture media
 Molecular method: for detection of DNA of toxin
producing organism in specimens are now being developed.
Endotoxins
 They are lipopolysaccharides (LPS) present on Gram –ve bacterial
cell wall.
 The lipid A portion of LPS is responsible for endotoxin activity.
 They are the integral part of the bacteria and are released as
bacteria lyse.
 They are primarily responsible for sepsis and septic shock.
 Endotoxin mediated toxicity include: Fever, activation of
complement, thrombocytopenia, disseminated intra vascular
coagulation, decreased peripheral circulation and perfusion of
organs, shock and death
Mechanism of bacterial pathogenesis
Infecting Dose
 Adequate number of bacteria is needed for successful infections
 The dose of infection depends on virulence of bacteria,
organisms of high virulence can produce severe infection in small
numbers
 Bacterial virulence is the sum total od invasiveness to tissues,
capacity of multiplication in tissues and production of toxin
 Minimum lethal dose (MLD) is the minimum number or
weight of organisms or toxin in micrograms needed to kill a
particular species of animal when administered by a certain
route.
 Minimum infecting dose (MID) is the minimum
number of bacteria required to produce clinical evidence of
infection in a susceptible animal when administered under
standard condition.
 LD 50 and ID 50
 Organisms like S. typhi can infect in small doses while S.
typhimurium require large number of organisms to make
infection
 Enhancement in virulence is called exaltation which can
be achieved by serial passage in susceptible hosts.
 Reduction of virulence is termed are attenuation which
can be attained by serial passage of the organism through
un favourable hosts, prolonged storage, growth under high
temperature, repeated cultures in artificial media and in
presence of weak antiseptic substances.

More Related Content

PPT
Bacterial Pathogenesis
PPT
4 bacterial infection and pathogenesis
PPTX
Bacterial pathogenesis
PPTX
Pathogenesis i bacterial virulence factors
PPT
07 pathogenicity and_virulence
PPTX
Mechanism of bacterial pathogenesis and virulence
PPTX
Bacterial Pathogenesis
PDF
Microbial pathogenicity
Bacterial Pathogenesis
4 bacterial infection and pathogenesis
Bacterial pathogenesis
Pathogenesis i bacterial virulence factors
07 pathogenicity and_virulence
Mechanism of bacterial pathogenesis and virulence
Bacterial Pathogenesis
Microbial pathogenicity

What's hot (20)

PPTX
Adhesion, invasion and colonization
PPT
Bacterial Virulence
PPTX
Infection and bacterial virulence factors
PPTX
Immunity to Microbes
PPTX
GENERAL PROPERTIES OF VIRUSES
PPTX
Bacterial virulence factors
PPTX
Endospore
PPTX
Host microbe interaction
PPT
Microbial pathogenicity
PDF
History of virology
PPTX
Humoral immune response
PPTX
Pathogenic mechanisms of microbes of medical importance
PPT
5 immune defense against bacterial pathogens
PPTX
Vaccines
PPTX
HISTOPLASMOSIS.pptx
PPTX
Microbes and diseases
PPTX
Human microbial flora
PPTX
Fungal diseases(MYCOSES)
PPTX
Bacterial physiology ppt
Adhesion, invasion and colonization
Bacterial Virulence
Infection and bacterial virulence factors
Immunity to Microbes
GENERAL PROPERTIES OF VIRUSES
Bacterial virulence factors
Endospore
Host microbe interaction
Microbial pathogenicity
History of virology
Humoral immune response
Pathogenic mechanisms of microbes of medical importance
5 immune defense against bacterial pathogens
Vaccines
HISTOPLASMOSIS.pptx
Microbes and diseases
Human microbial flora
Fungal diseases(MYCOSES)
Bacterial physiology ppt
Ad

Similar to Mechanism of bacterial pathogenesis (20)

PPTX
Bacterial pathogenesis
PPTX
Microbes, Man and Environment (Microbial pathogenicity) .pptx
PPTX
host pathogen interaction, Mechanism of pathogenesis
PDF
Microbial_Pathogenicity.pdf
PPTX
Microbial Pathogenicity (classification and steps).pptx
PPT
Pathogenesis of infection
PPTX
BACTERIAL PATHOGENICITY AND VIRULENCE FACTORS.pptx
PPTX
4. Normal Flora and Bacterial Pathogenesis.pptx
PPTX
molecular mechanism of pathogenesis
PPTX
pathogenicity_of_microbes (1).pptx
PPT
Bacterial Phathogenesis and associated notes .ppt
PPT
Lecture 6- Bacteria- Pathathogenesis.ppt
PPTX
Medical Microbiology
PPTX
Introduction of medical microbiology unit 1
PPT
Lecture 6- Bacteria- Phathogenesis.ppt microbiology-bacteriology, virulence
PPTX
Lecture 6- Bacteria- Phathogenesis [Autosaved].pptx
PPT
Lecture 6- Bacteria- Phathogenesis.ppt
PPT
Lecture 6- Bacteria- Phathogenesis.ppt
PDF
Bacterial Pathogenesis and Virulence Factors
Bacterial pathogenesis
Microbes, Man and Environment (Microbial pathogenicity) .pptx
host pathogen interaction, Mechanism of pathogenesis
Microbial_Pathogenicity.pdf
Microbial Pathogenicity (classification and steps).pptx
Pathogenesis of infection
BACTERIAL PATHOGENICITY AND VIRULENCE FACTORS.pptx
4. Normal Flora and Bacterial Pathogenesis.pptx
molecular mechanism of pathogenesis
pathogenicity_of_microbes (1).pptx
Bacterial Phathogenesis and associated notes .ppt
Lecture 6- Bacteria- Pathathogenesis.ppt
Medical Microbiology
Introduction of medical microbiology unit 1
Lecture 6- Bacteria- Phathogenesis.ppt microbiology-bacteriology, virulence
Lecture 6- Bacteria- Phathogenesis [Autosaved].pptx
Lecture 6- Bacteria- Phathogenesis.ppt
Lecture 6- Bacteria- Phathogenesis.ppt
Bacterial Pathogenesis and Virulence Factors
Ad

Recently uploaded (20)

PPTX
Protein & Amino Acid Structures Levels of protein structure (primary, seconda...
PDF
VARICELLA VACCINATION: A POTENTIAL STRATEGY FOR PREVENTING MULTIPLE SCLEROSIS
PPTX
EPIDURAL ANESTHESIA ANATOMY AND PHYSIOLOGY.pptx
PDF
Biophysics 2.pdffffffffffffffffffffffffff
PDF
HPLC-PPT.docx high performance liquid chromatography
DOCX
Viruses (History, structure and composition, classification, Bacteriophage Re...
PPT
POSITIONING IN OPERATION THEATRE ROOM.ppt
PPT
Chemical bonding and molecular structure
PDF
Unveiling a 36 billion solar mass black hole at the centre of the Cosmic Hors...
PPTX
Introduction to Fisheries Biotechnology_Lesson 1.pptx
PPTX
Production technology of seed spices,,,,
PPTX
2. Earth - The Living Planet earth and life
PPT
The World of Physical Science, • Labs: Safety Simulation, Measurement Practice
PDF
Crime Scene Investigation: A Guide for Law Enforcement (2013 Update)
PPTX
GEN. BIO 1 - CELL TYPES & CELL MODIFICATIONS
PPTX
famous lake in india and its disturibution and importance
PDF
bbec55_b34400a7914c42429908233dbd381773.pdf
PPTX
microscope-Lecturecjchchchchcuvuvhc.pptx
PPTX
cpcsea ppt.pptxssssssssssssssjjdjdndndddd
PPTX
Derivatives of integument scales, beaks, horns,.pptx
Protein & Amino Acid Structures Levels of protein structure (primary, seconda...
VARICELLA VACCINATION: A POTENTIAL STRATEGY FOR PREVENTING MULTIPLE SCLEROSIS
EPIDURAL ANESTHESIA ANATOMY AND PHYSIOLOGY.pptx
Biophysics 2.pdffffffffffffffffffffffffff
HPLC-PPT.docx high performance liquid chromatography
Viruses (History, structure and composition, classification, Bacteriophage Re...
POSITIONING IN OPERATION THEATRE ROOM.ppt
Chemical bonding and molecular structure
Unveiling a 36 billion solar mass black hole at the centre of the Cosmic Hors...
Introduction to Fisheries Biotechnology_Lesson 1.pptx
Production technology of seed spices,,,,
2. Earth - The Living Planet earth and life
The World of Physical Science, • Labs: Safety Simulation, Measurement Practice
Crime Scene Investigation: A Guide for Law Enforcement (2013 Update)
GEN. BIO 1 - CELL TYPES & CELL MODIFICATIONS
famous lake in india and its disturibution and importance
bbec55_b34400a7914c42429908233dbd381773.pdf
microscope-Lecturecjchchchchcuvuvhc.pptx
cpcsea ppt.pptxssssssssssssssjjdjdndndddd
Derivatives of integument scales, beaks, horns,.pptx

Mechanism of bacterial pathogenesis

  • 1. B Y M S . J I G I S H A P A N C H O L I H E A D D E P T . O F B I O C H E M I S T R Y & M I C R O B I O L O G Y I N D I A N I N S T I T U T E O F A Y U R V E D I C P H A R M A C E U T I C A L S C I E N C E S G U J A R A T A Y U R V E D U N I V E R S I T Y J A M N A G A R Mechanism of Bacterial Pathogenesis
  • 3. Introduction  Humans and animals have abundant bacterial flora that are usually harmless.  A general balance exists between host and his environment.  The host- parasite interaction is influenced by host factors as well as the infecting microbe.  The outcome of this interaction can range from no demonstrable effect to death.  Majority of the free living organisms are saprophytes.
  • 5. Commensal  Commensals live in complete harmony with the animal body (host) without causing any harm to it.  The commensals constitute the normal bacterial flora of the body, such as S. epidermidis of skin and E. coli of gastrointestinal tract.  They subsist on secretions, food residues or waste products of the body.  They serve important functions in their hosts, like production of vitamins, protection of host from colonisation with pathogenic organism etc.
  • 6. Opportunistic Pathogen  These are the commensals or saprophytes which can produce disease when the body resistance is lowered.  Example:  Candida albicans – a causal agent of opportunistic oral and genital infections in humans  Staphylococcus aureus- occurs as commensal on human skin but may cause Staph infections
  • 7. Pathogen  A micro organism capable of producing disease is called as pathogen.  Pathogenicity is the ability of a class of bacteria (Pathogen) to produce disease.  Examples:  Bacillus anthracis causes anthrax  Clostridium tetani causes tetanus  Salmonella typhi causes typhoid
  • 8. Virulence  Virulence is the measure of the degree of pathogenicity and depends on invasiveness and toxigenecity of the organism.  The ability of a bacteria to cause disease is described in terms of the number of infecting bacteria, the route of entry into the body, the effects of host defense mechanisms and intrinsic characteristics of the bacteria called as virulence factors.
  • 9. Infection  Infection may be defined as lodgement and multiplication of an infectious agent in the body.  All infections do not invariably result in disease.  Some infections may remain asymptomatic and others may lead to development of signs and symptoms (disease) after break down of host- parasite relationship in favour of the parasite.
  • 10. Portal of Entry  The infectious agent enters the body by one of the following routes:  Oral  Respiratory  Genitourinary  Conjunctiva  Cutaneous
  • 11. Incubation Period  The time interval between the entry of the infectious agent and the onset of clinical manifestations of disease is called incubation period.  The infective agent, after reaching the selective tissue, undergoes multiplication during this period.  The period may be as short as minutes to as long as thirty years in the case of variant Creutzfeldt- Jakob disease
  • 12. Clinical Manifestation  An infection that does not cause any detectable manifestation is known as in apparent or subclinical infection.  A person with symptomless infection is called as carrier.  In some diseases, either because of inadequate treatment or immune response, the infectious agent us not eliminated, leading to carrier state.  Carriers may be temporary or chronic.
  • 13.  Temporary carrier state lasts for less than six months, whereas the chronic carrier is the one who excretes the disease producing organisms for indefinite period of several years or throughout life.  Examples: Cholera, polio, diphtheria, meningitis, typhoid etc.  Following infection, some pathogens may remain in latent or dormant form in host tissues and proliferate when host resistance is lowered producing clinical disease. This is called as Latent infection. Example: HIV
  • 14.  Primary infection is referred to the first or initial infection caused by an infecting organism.  Subsequent infections by the same parasite in the host is called as re infection.  When the body resistance of a patient is lowered by a pre existing infectious disease or during some treatment, a new micro organism sets up an infection which is called as secondary infection. Example: A vaginal yeast infection after taking antibiotics to remove bacterial infection.
  • 15.  When a new infection from patient or healthy staff carrier is set up in an already diseased person, it is called as cross infection.  Cross infections acquired in hospitals are called as hospital acquired or nosocomial infections.  Infection where the typical or characteristic manifestations of a particular disease is lacking, it is called as atypical infection. Eg: Atypical mycobacterial infections in HIV patients  An iatrogenic infection is defined as physician induced infection resulting from drug therapy or diagnostic procedure, eg. Hepatitis B following blood transfusion.
  • 16. Evolution of Infection  From the portal entry the parasites may directly invade the tissue or may pass through lymphatic channels into blood stream for dissemination into internal organs.  In majority of the instances, the parasites get destroyed by the host defense mechanisms.  When the host resistance fails, an acute inflammatory response is developed which is characterized by vascular dilatation, marked exudation of plasma and accumulation of leucocytes with the formation of pus.  The pus forming bacteria are termed pyogenic, eg. S. aureus, S. pyogenes.
  • 18. Capsule  Capsule is one of the most important virulence factors.  They surround many bacterial cells which shield the bacteria from immune and phagocytic response.  They are made up of either carbohydrates or proteins
  • 19.  Capsule inhibits phagocytosis by means of several ways:  1. Capsule prevents interaction between antibody and C3 bound to outer membrane of bacteria and their respective receptors on phagocytic cells.  Complement activation is inhibited by the capsule. 
  • 20. Adhesins  The pathogenesis of many bacteria depend on the ability to adhere to mucosal cells as a first step.  With adhesion factors, many bacteria adhere to epithelial or endothelial cell linings of bladder, intestine and blood vessels.  Types: Pili Lipopolysaccharide M proteins
  • 21.  Pili: in most cases pili serve as adhesion factor. Many of the adhesin proteins are present at the tip of pili and binds tightly to the target tissue.  Examples of bacteria producing pili as adhesion factor:  E.coli  Neisseria gonorrhoeae  Lipopolysaccharides: They are present in the outer membrane of gram –ve bacteria.
  • 22.  M protein: the expression of M proteins on the cell membrane of bacteria mediates their adherence to epithelial cells as seen in S. pyogenes that causes pharyngitis, which appears to be directly related to the production of M proteins.
  • 23. Invasiveness  Invasiveness of bacteria appears to be multifactorial and complex process. Invasive bacteria either destroy the barrier or penetrate into the cells of the barrier.  Examples:  1. Shigella: a series of invasive proteins are involved: a. Proteins called as “invasion plasmid antigens (IPA)” expressed on outer membrane permit the bacterium to bind to the luminal surface of mucosal M cells of intestine then endocytosis occurs which is followed by rapid exit of the bacterium from the endosome into the cytoplasm.
  • 24. b. Another protein, known as “intracellular spread protein (ICS)” expressed on the outer membrane of the bacterium, allows to interact with the host cell integrins. Following interaction, the bacterium travels towards the cell membrane which forms a protrusion and fuses with cell membranes of adjacent cells, thereby enabling Shigella to diffuse from cell to cell.
  • 25.  2. Enteropathogenic Yersinia: they secrete an invasion protein which promotes binding of bacteria to the host cells, which in turn stimulates the cell to invaginate and take in the bacteria.  3. Neisseria gonorrhoea: with its pili adhere to mucosal cells. The bacteria also contains an enzyme that dissolves mucosal cell lining and thereby enables the organism to penetrate submucosal tissues.
  • 26. Exoenzymes  Many bacteria release enzymes that can damage host tissue in a variety of mechanisms:  1. Enzymes that break down collagen (eg.: collagenase, hyaluronidase) and fibrin (eg: fibrinolysins) allows better penetration of microbes into tissues.  2. Enzymes that break down cellular material (Eg: proteases, lecithinases) are associated with many Clostridia  3. Enzymes that modify and inactivate antibiotics (eg. Beta lactamase) hydrolyses the beta lactum ring of the antibiotics. The beta lactamase for penicillin and cephalosporin are called penicillinase and cephalosporinase respectively.
  • 28. Toxins  Bacterial toxins directly harm tissue or trigger destructive biological activities.  They are classified into two categories: Exotoxins and Endotoxins
  • 29. Exotoxins  They are proteins produced and released extra cellularly from the bacterial cell to cause toxicity.  They are produced by both Gram +ve and Gram –ve bacteria.  In many cases the toxin is encoded by the plasmid, eg: LT and ST toxins of E.coli, tetanus toxin of Cl. tetani or a lysogenic phage, eg: C. diphtheriae, Cl. botulinum
  • 31.  Most exotoxins have two structural domains, “A” subunit (active domain)that causes cell cytotoxicity and “B” domain (binding domain) subunit that binds the A domain to specific cellular receptors.  “A “subunit is transferred to the interior of the cell, where the cell injury is induced
  • 32. Functional types of Exotoxins  Enterotoxins: Affect gastrointestinal tract and include cholera toxin, E.coli toxin  Neurotoxins: Affect nervous system and include botulinum toxin, tetanus toxin  Cytotoxin: Affect cells in a variety of tissues and include diphtheria toxin, pseudomonas toxin A
  • 33. Identification of exotoxins  Ileal loop test: Ligated loops of ileum are inoculated with enterotoxin producing bacteria (V. cholerae, Enterotoxigenic E.coli), accumulation of fluid occur in the lumen in the organism is toxigenic.  Cell culture test: to monolayers of sensitive cells (eg: Vero cells) bacteria free culture filtrate is added and incubated. The monolayer will be disrupted if the filtrate contains toxin (eg Vero cytotoxin of E.coli)
  • 34.  Serological test (Immunoassay): Since the enterotoxin are immunogenic, antisera can be used to detect the presence of toxin in specimens (eg: faecal material) or in culture media  Molecular method: for detection of DNA of toxin producing organism in specimens are now being developed.
  • 35. Endotoxins  They are lipopolysaccharides (LPS) present on Gram –ve bacterial cell wall.  The lipid A portion of LPS is responsible for endotoxin activity.  They are the integral part of the bacteria and are released as bacteria lyse.  They are primarily responsible for sepsis and septic shock.  Endotoxin mediated toxicity include: Fever, activation of complement, thrombocytopenia, disseminated intra vascular coagulation, decreased peripheral circulation and perfusion of organs, shock and death
  • 37. Infecting Dose  Adequate number of bacteria is needed for successful infections  The dose of infection depends on virulence of bacteria, organisms of high virulence can produce severe infection in small numbers  Bacterial virulence is the sum total od invasiveness to tissues, capacity of multiplication in tissues and production of toxin  Minimum lethal dose (MLD) is the minimum number or weight of organisms or toxin in micrograms needed to kill a particular species of animal when administered by a certain route.
  • 38.  Minimum infecting dose (MID) is the minimum number of bacteria required to produce clinical evidence of infection in a susceptible animal when administered under standard condition.  LD 50 and ID 50  Organisms like S. typhi can infect in small doses while S. typhimurium require large number of organisms to make infection
  • 39.  Enhancement in virulence is called exaltation which can be achieved by serial passage in susceptible hosts.  Reduction of virulence is termed are attenuation which can be attained by serial passage of the organism through un favourable hosts, prolonged storage, growth under high temperature, repeated cultures in artificial media and in presence of weak antiseptic substances.